Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity
Xavier Nadal, Carmen del Río, S. Casano, et al.
British Journal of Pharmacology (2017) Vol. 174, Iss. 23, pp. 4263-4276
Open Access | Times Cited: 108

Showing 26-50 of 108 citing articles:

Natural products targeting mitochondria: emerging therapeutics for age-associated neurological disorders
Zhibin Liang, António Currais, David Soriano‐Castell, et al.
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107749-107749
Open Access | Times Cited: 52
Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: An overview
Carlos Villarroel-Vicente, Sergio Gutiérrez-Palomo, Jordi Ferri, et al.
European Journal of Medicinal Chemistry (2021) Vol. 221, pp. 113535-113535
Closed Access | Times Cited: 46
Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease
Madilyn Coles, Genevieve Z. Steiner-Lim, Tim Karl
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 31
PPARs and Their Neuroprotective Effects in Parkinson’s Disease: A Novel Therapeutic Approach in α-Synucleinopathy?
Isaac Pérez-Segura, Alberto Santiago-Balmaseda, Luis Daniel Rodríguez-Hernández, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3264-3264
Open Access | Times Cited: 17
(‒)-Cannabidiolic Acid, a Still Overlooked Bioactive Compound: An Introductory Review and Preliminary Research
Marialuisa Formato, Giuseppina Crescente, Monica Scognamiglio, et al.
Molecules (2020) Vol. 25, Iss. 11, pp. 2638-2638
Open Access | Times Cited: 48
Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer’s, Parkinson’s, and Huntington’s Diseases
Catalina Pérez-Olives, Rafael Rivas‐Santisteban, Jaume Lillo, et al.
Advances in experimental medicine and biology (2020), pp. 81-92
Closed Access | Times Cited: 43
A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT1A Receptors
Carolina Echeverry, Giselle Prunell, Camila Narbondo, et al.
Neurotoxicity Research (2020) Vol. 39, Iss. 2, pp. 335-348
Closed Access | Times Cited: 42
Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids
Rafael Franco, Rafael Rivas‐Santisteban, Irene Reyes‐Resina, et al.
Pharmacological Research (2020) Vol. 158, pp. 104801-104801
Closed Access | Times Cited: 40
From obesity to Alzheimer's disease through insulin resistance
Simona Terzo, Antonella Amato, Flavia Mulè
Journal of Diabetes and its Complications (2021) Vol. 35, Iss. 11, pp. 108026-108026
Open Access | Times Cited: 40
Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System
Ana Lago-Fernandez, Sara Zarzo-Arias, Nadine Jagerovic, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1001-1001
Open Access | Times Cited: 39
Biosynthesis of Phytocannabinoids and Structural Insights: A Review
Rasiravathanahalli Kaveriyappan Govindarajan, Awdhesh Kumar Mishra, Kiu-Hyung Cho, et al.
Metabolites (2023) Vol. 13, Iss. 3, pp. 442-442
Open Access | Times Cited: 16
Analysis of phytocannabinoids in hemp seeds, sprouts and microgreens
E. Ferri, Fabiana Russo, Maria Angela Vandelli, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 245, pp. 116181-116181
Closed Access | Times Cited: 6
Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases
Cristina Prandi, Marco Blangetti, Dvora Namdar, et al.
Molecules (2018) Vol. 23, Iss. 7, pp. 1526-1526
Open Access | Times Cited: 42
Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity
Belén Palomares, Francisco Ruíz-Pino, Martín Garrido‐Rodriguez, et al.
Biochemical Pharmacology (2019) Vol. 171, pp. 113693-113693
Open Access | Times Cited: 40
Natural Salicylates and Their Roles in Human Health
Fatema Yeasmin, Hyong Woo Choi
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9049-9049
Open Access | Times Cited: 36
Development of a novel cannabinoid-loaded microemulsion towards an improved stability and transdermal delivery
Chulhun Park, Jieyu Zuo, Vijay Somayaji, et al.
International Journal of Pharmaceutics (2021) Vol. 604, pp. 120766-120766
Closed Access | Times Cited: 31
Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors
Iu Raïch, Rafael Rivas‐Santisteban, Alejandro Lillo, et al.
Pharmacological Research (2021) Vol. 174, pp. 105970-105970
Open Access | Times Cited: 30
Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios
Swati Katoch, Vinesh Sharma, Vikram Patial
World Journal of Gastroenterology (2022) Vol. 28, Iss. 28, pp. 3535-3554
Open Access | Times Cited: 22
Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs
Gabriel Garcia, Stephanie Kube, Sheila Carrera‐Justiz, et al.
Frontiers in Veterinary Science (2022) Vol. 9
Open Access | Times Cited: 21
Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds
Brittney R. Lins, Chidozie C. Anyaegbu, Sarah C. Hellewell, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 12
Pharmacokinetics and tolerability of single-dose enteral cannabidiol and cannabidiolic acid rich hemp in horses (Equus caballus)
Alexander Thomson, Taralyn M. McCarrel, Alexander Zakharov, et al.
Frontiers in Veterinary Science (2024) Vol. 11
Open Access | Times Cited: 4
Cannabis in Veterinary Medicine: Cannabinoid Therapies for Animals
Joshua A. Hartsel, Kyle Boyar, Andrew Pham, et al.
Springer eBooks (2019), pp. 121-155
Closed Access | Times Cited: 34
Efficacy of Phytocannabinoids in Epilepsy Treatment: Novel Approaches and Recent Advances
Aaron Mark Farrelly, Styliani Vlachou, Konstantinos Grintzalis
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 8, pp. 3993-3993
Open Access | Times Cited: 27
Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders
Sanjay Sanjay, Anshul Sharma, Hae‐Jeung Lee
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1914-1914
Open Access | Times Cited: 24
Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research
Diego Caprioglio, Hawraz Ibrahim M. Amin, Orazio Taglialatela‐Scafati, et al.
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1084-1084
Open Access | Times Cited: 19

Scroll to top